Sickle Cell Disease

Showing NaN - NaN of 41

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

The Living With a Long-Term Condition Study

Recruiting
  • Asthma
  • +44 more
  • Living with LTC Questionnaire
  • London, United Kingdom
    King's College London
Oct 10, 2023

Sickle Cell Disease Trial in Adana, Mersin (NDec - oral decitabine-tetrahydrouridine, HU - Hydroxyurea, Placebo)

Recruiting
  • Sickle Cell Disease
  • NDec - oral decitabine-tetrahydrouridine
  • +2 more
  • Oakland, California
  • +39 more
Jan 24, 2023

Sickle Cell Disease Trial in Worldwide (VIT-2763 120 mg, VIT-2763 360 mg, VIT-2763 240 mg)

Recruiting
  • Sickle Cell Disease
  • VIT-2763 120 mg
  • +4 more
  • Birmingham, Alabama
  • +12 more
Jan 20, 2023

A Long-term Follow-up Study in Subjects Who Received CTX001

Enrolling by invitation
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • New York, New York
  • +12 more
Nov 18, 2022

Sickle Cell Disease Trial in Netherlands, United Kingdom, United States (CSL889)

Recruiting
  • Sickle Cell Disease
  • CSL889
  • Chicago, Illinois
  • +12 more
Oct 11, 2022

Sickle Cell Disease Trial in Worldwide (Etavopivat Tablets, Placebo Tablets)

Recruiting
  • Sickle Cell Disease
  • Etavopivat Tablets Low dose
  • +3 more
  • Birmingham, Alabama
  • +77 more
Oct 11, 2022

Sickle Cell Disease Trial in Worldwide (Voxelotor)

Active, not recruiting
  • Sickle Cell Disease
  • Little Rock, Arkansas
  • +47 more
Sep 28, 2022

Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (Voxelotor)

Enrolling by invitation
  • Sickle Cell Disease
  • Washington, District of Columbia
  • +10 more
Sep 27, 2022

Sickle Cell Disease Trial in London (Voxelotor)

Terminated
  • Sickle Cell Disease
  • London, United Kingdom
  • +5 more
Aug 29, 2022

Sickle Cell Disease Trial in France, United Kingdom, United States (Red Blood Cell, Standard of care)

Recruiting
  • Sickle Cell Disease
  • Red Blood Cell
  • Standard of care
  • Tuscaloosa, Alabama
  • +19 more
Aug 23, 2022

Sickle Cell Disease Trial in Worldwide (IMR-687, Placebo)

Terminated
  • Sickle Cell Disease
  • Birmingham, Alabama
  • +48 more
May 9, 2022

Sickle Cell Disease Trial in United Kingdom, United States (IMR-687, Placebo)

Completed
  • Sickle Cell Disease
  • Oakland, California
  • +12 more
Mar 22, 2022

Sickle Cell Disease Trial in United Kingdom, United States (IMR-687)

Active, not recruiting
  • Sickle Cell Disease
  • Farmington, Connecticut
  • +6 more
Mar 2, 2022

Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (Voxelotor)

Recruiting
  • Sickle Cell Disease
  • Oakland, California
  • +17 more
Jan 13, 2022

Cancer, COPD, Asthma Trial in London (SELF-BREATHE)

Recruiting
  • Cancer
  • +11 more
  • SELF-BREATHE
  • London, United Kingdom
    King's College Hospital NHS Foundation TRUST
Sep 1, 2021

Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (IW-1701, Placebo)

Completed
  • Sickle Cell Disease
  • Orange, California
  • +36 more
Jul 18, 2021

Sickle Cell Disease Trial in London (Aes-103, Placebo)

Terminated
  • Sickle Cell Disease
  • London, United Kingdom
    Quintiles Ltd. - Quintiles Drug Research Unit, 6 Newcomen Street
May 3, 2021

Sickle Cell Disease Trial in Worldwide (Ticagrelor)

Completed
  • Sickle Cell Disease
  • Edegem, Belgium
  • +7 more
May 7, 2021

Sickle Cell Disease Trial in Worldwide (Ticagrelor, Placebo)

Terminated
  • Sickle Cell Disease
  • Fort Lauderdale, Florida
  • +54 more
Mar 15, 2021

Sickle Cell Disease Trial in Worldwide (voxelotor, Placebo)

Completed
  • Sickle Cell Disease
  • Birmingham, Alabama
  • +61 more
Jan 5, 2021

Multi-Center Study of Iron Overload: Pilot Study

Completed
  • Sickle Cell Disease
  • +2 more
    • Oakland, California
    • +2 more
    Sep 22, 2020

    Multi-Center Study of Iron Overload: Survey Study (MCSIO)

    Completed
    • Sickle Cell Disease
    • +2 more
      • Oakland, California
      • +7 more
      Sep 22, 2020